ACUTE AND LONG-TERM NEPHROTOXICITY OF CISPLATINUM IN MAN

被引：71

作者：

GROTH, S ^{[1
]}

NIELSEN, H ^{[1
]}

SORENSEN, JB ^{[1
]}

CHRISTENSEN, AB ^{[1
]}

PEDERSEN, AG ^{[1
]}

RORTH, M ^{[1
]}

机构：

[1] FINSEN INST,DEPT CHEMOTHERAPY R2-5,DK-2100 COPENHAGEN O,DENMARK

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1986年 / 17卷 / 02期

关键词：

D O I：

10.1007/BF00306754

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：191 / 196

页数：6

共 24 条

[1]

CHANTLER C, 1969, CLIN SCI, V37, P169

[2]

CHRISTENSEN AB, 1982, NUCLEAR MED BIOL, V1, P609

[3]

CLEARE M J, 1977, Journal of Clinical Hematology and Oncology, V7, P1

[4] RADIONUCLIDE CLEARANCE TECHNIQUES [J].

COHEN, ML .

SEMINARS IN NUCLEAR MEDICINE, 1974, 4 (01) :23-38

[5] CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].

EINHORN, LH ;

DONOHUE, J .

ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298

[6]

FRICK GA, 1979, CANCER TREAT REP, V63, P13

[7]

GONZALEZVITALE JC, 1977, CANCER, V39, P1362, DOI 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO

[8]

2-N

[9] CR-51-EDTA CLEARANCE DETERMINED BY ONE PLASMA SAMPLE [J].

GROTH, S ;

AASTED, M .

CLINICAL PHYSIOLOGY, 1981, 1 (04) :417-425

[10] CDTE-DETECTOR REGISTRATION OF TC-99M-DTPA CLEARANCE - AN ASSESSMENT OF KIDNEY-FUNCTION WITHOUT BLOOD-SAMPLING [J].

GROTH, S ;

CHRISTENSEN, AB ;

NIELSEN, H .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1983, 8 (06) :242-244

← 1 2 3 →